Small EV in plasma of triple negative breast cancer patients induce intrinsic apoptosis in activated T cells

Small extracellular vesicles (sEV) in TNBC patients' plasma promote T cell dysfunction and tumor progression. Here we show that tumor cell-derived exosomes (TEX) carrying surface PDL-1, PD-1, Fas, FasL, TRAIL, CTLA-4 and TGF-& beta;1 induce apoptosis of CD8(+)T and CD4(+)T cells but spare B and NK cells. Inhibitors blocking TEX-induce receptor/ligand signals and TEX pretreatments with proteinase K or heat fail to prevent T cell apoptosis. Cytochalasin D, Dynosore or Pit Stop 2, partly inhibit TEX uptake but do not prevent T cell apoptosis. TEX entry into T cells induces cytochrome C and Smac release from mitochondria and caspase-3 and PARP cleavage in the cytosol. Expression of survival proteins is reduced in T cells undergoing apoptosis. Independently of external death receptor signaling, TEX entry into T cells induces mitochondrial stress, initiating relentless intrinsic apoptosis, which is responsible for death of activated T cells in the tumor-bearing hosts. The abundance of TEX in cancer plasma represents a danger for adoptively transferred T cells, limiting their therapeutic potential. Tumor cell-derived exosomes from triple negative breast cancer cells that are taken up by recipient T cells induce intrinsic apoptosis, leading to cell death, with implications for adoptive cancer immunotherapy.

Automated summary

Small extracellular vesicles (sEV) in TNBC patients' plasma promote T cell dysfunction and tumor progression. Tumor cell-derived exosomes (TEX) carrying surface proteins induce apoptosis of CD8(+)T and CD4(+)T cells but spare B and NK cells. TEX entry into T cells induces mitochondrial stress, initiating intrinsic apoptosis, which limits the therapeutic potential of adoptively transferred T cells.